Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (1) , 100840
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 37 references indexed in Scilit:
- Dilated cardiomyopathy: the complexity of a diverse genetic architectureNature Reviews Cardiology, 2013
- Cardiac myosin binding protein-C restricts intrafilament torsional dynamics of actin in a phosphorylation-dependent mannerProceedings of the National Academy of Sciences, 2012
- Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domainJournal of Molecular and Cellular Cardiology, 2012
- The Myosin-binding Protein C Motif Binds to F-actin in a Phosphorylation-sensitive MannerJournal of Biological Chemistry, 2009
- Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscleJournal of Molecular and Cellular Cardiology, 2008
- Fluorescence Spectroscopic Profiling of Compound LibrariesJournal of Medicinal Chemistry, 2008
- Cardiac Myosin-Binding Protein C Is Required for Complete Relaxation in Intact MyocytesCirculation Research, 2007
- Structural Dynamics of Actin during Active Interaction with Myosin: Different Effects of Weakly and Strongly Bound Myosin HeadsBiochemistry, 2004
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C 1 1Edited by J. KarnJournal of Molecular Biology, 1999